Identification of a mitochondrial defect gene signature reveals NUPR1 as a key regulator of liver cancer progression

Publisher： John Wiley & Sons Inc

E-ISSN： 1527-3350|62|4|1174-1189

ISSN： 0270-9139

Source： HEPATOLOGY, Vol.62, Iss.4, 2015-10, pp. : 1174-1189

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Identification of a mitochondrial defect gene signature reveals NUPR1 as a key regulator of liver cancer progression

By  

HEPATOLOGY, Vol. 270-9139, Iss. 4, 2015-10 ,pp. : 1174-1189

John Wiley & Sons Inc

Access to resources Recommend Favorite

Caveolin-1 functions as a key regulator of 17β-estradiol-mediated autophagy and apoptosis in BT474 breast cancer cells

By            

International Journal of Molecular Medicine, Vol. 34, Iss. 3, 2014-01 ,pp. : 822-827

Spandidos Publications

Access to resources Recommend Favorite

Negative modulation of the epigenetic regulator, UHRF1, by thyroid hormone receptors suppresses liver cancer cell growth

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 1, 2015-07 ,pp. : 37-49

John Wiley & Sons Inc

Access to resources Recommend Favorite

Conjugated bile acid–activated S1P receptor 2 is a key regulator of sphingosine kinase 2 and hepatic gene expression

By  

HEPATOLOGY, Vol. 61, Iss. 4, 2015-04 ,pp. : 1216-1226

John Wiley & Sons Inc

Access to resources Recommend Favorite

Calcitonin gene‐related peptide: key regulator of cutaneous immunity

By  

ACTA PHYSIOLOGICA (ELECTRONIC), Vol. 213, Iss. 3, 2015-03 ,pp. : 586-594

John Wiley & Sons Inc

Access to resources Recommend Favorite